Patients who suffered from an adverse event after their first AF diagnosis showed a higher frequency of thrombin-activated CD8+PAR1+ T cells at baseline when compared to patients who did not develop MACEs during follow-up (Figure 6A). Here, CD8A is linked to atrial fibrillation.